Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2101]

EHA 2015: Adding elotuzumab to standard treatment for multiple myeloma significantly reduced the risk of disease progression

EHA 2015: Adding elotuzumab to standard treatment for multiple myeloma significantly reduced the risk of disease...

Comorbid conditions associated with worse Lung cancer survival

Comorbid conditions associated with worse Lung cancer survival

Anti-tumor agent can be activated by natural response to cell stress

Anti-tumor agent can be activated by natural response to cell stress

'Cancer plans must put the patient at the centre of treatment’, conference hears

'Cancer plans must put the patient at the centre of treatment’, conference hears

Benefits of mammography screening outweigh adverse effects for women aged 50–69 years

Benefits of mammography screening outweigh adverse effects for women aged 50–69 years

Western diet after prostate cancer diagnosis associated with increased risk of death

Western diet after prostate cancer diagnosis associated with increased risk of death

ASCO 2015: Phase III study finds initial nivolumab-based treatment halts melanoma progression

ASCO 2015: Phase III study finds initial nivolumab-based treatment halts melanoma progression

Mortality and incidence for most breast cancer subtypes continue to decline

Mortality and incidence for most breast cancer subtypes continue to decline

Circulating tumour DNA in blood predicts recurrence of common lymphoma type

Circulating tumour DNA in blood predicts recurrence of common lymphoma type

Insights into a signalling process that enhances the effectiveness of cancer immunotherapy

Insights into a signalling process that enhances the effectiveness of cancer immunotherapy

More from ecancer